π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a single-center, open-label, single-dose phase I study to investiga...
Status
Completed
Location
Jiangsu Province Hospital Affiliated to Nanjing Madical University of Medicine
Start Date
2020-05-13
Trial ID
NCT04810533
Treatments Being Tested
This is a phase I study to assess the drug-drug interaction of SH-1028 tabl...
Status
Unknown
Location
the First Affiliated Hospital with Bengbu Medical College
Start Date
2021-04-06
Trial ID
NCT04808648
Treatments Being Tested
To assess the efficacy and safety of SH-1028 tablets versus placebo in stag...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2023-05-11
Trial ID
NCT06080776
Treatments Being Tested
This is a Phase 1, open-label study of SH-1028 with dose escalation and dos...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2018-04-25
Trial ID
NCT03603262
Treatments Being Tested
This is a Phase 1, open-label study of SH-1028 with dose escalation cohorts...
Status
Unknown
Location
Shanghai east hospital
Start Date
2018-09-13
Trial ID
NCT03618043
Treatments Being Tested
To evaluate the food-effect of SH-1028 Tablets by pharmacokinetics in healt...
Status
Unknown
Location
Multiple Locations
Start Date
2019-07
Trial ID
NCT03973632
Treatments Being Tested
A Phase II, Open Label, Single-arm Study to Assess the Safety and Efficacy ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-03
Trial ID
NCT03823807
Treatments Being Tested
To assess the efficacy and safety of SH-1028 tablets versus Gefitinib, a st...
Status
Unknown
Location
Multiple Locations
Start Date
2020-01-31
Trial ID
NCT04239833
Treatments Being Tested